Effective August 2, 2022, mdxhealth has acquired the Oncotype DX Genomic Prostate Score (GPS) test from Exact Sciences. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the press release.
Questions? Email: gps@mdxhealth.com

Interpret the Results

Exact Sciences makes understanding Oncotype DX Breast DCIS Score® test results as easy as possible.

Icon report

The Report:

A detailed Breast DCIS Score® report is generated for each patient

Icon score

The Score:

A quantitative score, based on a continuous scale of 0 to 100. The result reflects individual tumor biology and makes it easy for patients to understand their level of risk

Icon endpoint graph

The Endpoints:

Provides insight into the risk of the patient’s cancer recurring in the next 10 years (as another local DCIS tumor or as an invasive tumor)

Additional report information

In addition to the DCIS Score result, the report will include information, such as:

  • DCIS Score result is graphically displayed to illustrate the patient’s risk of having another DCIS local recurrence versus the chances of having an invasive local recurrence
  • Quantitative ER and PR single-gene scores presented on the final page

 

 

Getting the results

Most DCIS Score reports are available within 2 weeks from the date the specimen is received in the Exact Sciences lab. You can access the results through the online physician portal or receive the report by fax.

Icon doctor

Use our online physician portal

Order tests, access results, receive updates, and more in one place.

Sign up now

Here's how to order